AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue69,89259,11965,358
Cost of Revenue---
Gross Profit69,89259,11965,358
Operating Expenses
Research Development220,163141,827100,371
Selling General and Administrative50,71435,99219,120
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-200,985-118,700-54,133
Income from Continuing Operations
Total Other Income/Expenses Net2,514968203
Earnings Before Interest and Taxes-198,471-117,732-53,930
Interest Expense---
Income Before Tax-198,471-117,732-53,930
Income Tax Expense---426
Minority Interest---
Net Income From Continuing Ops-198,471-117,732-53,504
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-198,471-117,732-53,504
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-198,471-117,732-53,504